ENDONOVO THERAPEUTICS, INC. Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings of $2.18 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Income Statement › Other Income
us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings · last filed 2016-11-14
- ENDONOVO THERAPEUTICS, INC. fair value, assets and liabilities measured on recurring basis, gain (loss) included in earnings for the quarter ending 2016-09-30 was $1.00M.
| Period end | Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings 3 month | Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings 6 month | Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings 9 month |
|---|---|---|---|
| 2016-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $2.18M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.17M 10-Q · filed 2016-08-12 |